Screener
Fulgent Genetics, Inc. FLGT Finance Lease Liabilities
Finance Lease Liabilities at other companies
Other financials
Where this comes from
Reported directly by Fulgent Genetics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:FinanceLeaseLiabilityNoncurrent.
The source filing: Fulgent Genetics, Inc.’s 10-Q, filed May 1, 2026.
- Filed
- May 1, 2026, 7:08 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-199065
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Operating lease ROU asset, net | $7,687 | $4,961 |
| Operating lease liabilities, short term | $1,932 | $1,462 |
| Operating lease liabilities, long term | $6,008 | $3,781 |
| Finance lease ROU asset, net | $254 | $339 |
| Finance lease liabilities, short term | $271 | $360 |
| Finance lease liabilities, long term | — | — |
Item 1. Financial Statements.
FAQ
- What is Fulgent Genetics, Inc.'s finance lease liabilities?
- Fulgent Genetics, Inc. (FLGT) reported finance lease liabilities of $0 in Q1 2026.
- How has Fulgent Genetics, Inc.'s finance lease liabilities changed year-over-year?
- Fulgent Genetics, Inc.'s finance lease liabilities decreased by 100.0% year-over-year, from $271K to $0.
- What is the long-term trend for Fulgent Genetics, Inc.'s finance lease liabilities?
- Over 4 years (2021 to 2025), Fulgent Genetics, Inc.'s finance lease liabilities has grown at a -100.0% compound annual growth rate (CAGR), from $1.4M to $0.
- What does finance lease liabilities mean?
- Present value of future payments on leases classified as finance leases under ASC 842 — treated similarly to debt on the balance sheet.
Ask your AI about Fulgent Genetics, Inc.'s finance lease liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude